# Steven Madden, LTD.: financial statements, quarterly

SHOO · Nasdaq · CIK 913241 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/shoo.md) · [Financials](/companies/shoo/financials.md) · [Filings](/companies/shoo/filings.md) · [Insiders](/companies/shoo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/shoo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [550](/filings/0001628280-24-046673.md) | [517 d](/filings/0001628280-26-012995.md) | [551](/filings/0001628280-25-024142.md) | [522](/filings/0001628280-25-037646.md) | [621](/filings/0001628280-25-050843.md) | [579 d](/filings/0001628280-26-012995.md) | [551](/filings/0001628280-26-032774.md) | [556](/filings/0001628280-26-051368.md) | [664](/filings/0001628280-25-050843.md) | [750 d](/filings/0001628280-26-012995.md) | [650](/filings/0001628280-26-032774.md) | [663](/filings/0001628280-26-051368.md) |
| Cost of revenue | $m | [320](/filings/0001628280-24-046673.md) | [305 d](/filings/0001628280-26-012995.md) | [328](/filings/0001628280-25-024142.md) | [306](/filings/0001628280-25-037646.md) | [365](/filings/0001628280-25-050843.md) | [347 d](/filings/0001628280-26-012995.md) | [327](/filings/0001628280-26-032774.md) | [333](/filings/0001628280-26-051368.md) | [391](/filings/0001628280-25-050843.md) | [434 d](/filings/0001628280-26-012995.md) | [296](/filings/0001628280-26-032774.md) | [356](/filings/0001628280-26-051368.md) |
| Gross profit | $m | [233](/filings/0001628280-24-046673.md) | [215 d](/filings/0001628280-26-012995.md) | [225](/filings/0001628280-25-024142.md) | [217](/filings/0001628280-25-037646.md) | [260](/filings/0001628280-25-050843.md) | [235 d](/filings/0001628280-26-012995.md) | [226](/filings/0001628280-26-032774.md) | [226](/filings/0001628280-26-051368.md) | [277](/filings/0001628280-25-050843.md) | [320 d](/filings/0001628280-26-012995.md) | [357](/filings/0001628280-26-032774.md) | [310](/filings/0001628280-26-051368.md) |
| Operating income | $m | [82.7](/filings/0001628280-24-046673.md) | [39.9 d](/filings/0001628280-26-012995.md) | [56.7](/filings/0001628280-25-024142.md) | [46.9](/filings/0001628280-25-037646.md) | [74.6](/filings/0001628280-25-050843.md) | [46.7 d](/filings/0001628280-26-012995.md) | [53.5](/filings/0001628280-26-032774.md) | [(40.3)](/filings/0001628280-26-051368.md) | [31.4](/filings/0001628280-25-050843.md) | [36.2 d](/filings/0001628280-26-012995.md) | [98.7](/filings/0001628280-26-032774.md) | [39.3](/filings/0001628280-26-051368.md) |
| Income tax | $m | [19.6](/filings/0001628280-24-046673.md) | [4.4 d](/filings/0001628280-26-012995.md) | [13.7](/filings/0001628280-25-024142.md) | [11.3](/filings/0001628280-25-037646.md) | [19.4](/filings/0001628280-25-050843.md) | [10.2 d](/filings/0001628280-26-012995.md) | [13.1](/filings/0001628280-26-032774.md) | [3.9](/filings/0001628280-26-051368.md) | [4.6](/filings/0001628280-25-050843.md) | [7.1 d](/filings/0001628280-26-012995.md) | [23.5](/filings/0001628280-26-032774.md) | [10.1](/filings/0001628280-26-051368.md) |
| Net income | $m | [65.1](/filings/0001628280-24-046673.md) | [37.0 d](/filings/0001628280-26-012995.md) | [44.6](/filings/0001628280-25-024142.md) | [36.9](/filings/0001628280-25-037646.md) | [55.3](/filings/0001628280-25-050843.md) | [41.3 d](/filings/0001628280-26-012995.md) | [40.4](/filings/0001628280-26-032774.md) | [(39.5)](/filings/0001628280-26-051368.md) | [20.5](/filings/0001628280-25-050843.md) | [27.5 d](/filings/0001628280-26-012995.md) | [71.8](/filings/0001628280-26-032774.md) | [27.7](/filings/0001628280-26-051368.md) |
| Diluted EPS | $ per share | [0.87](/filings/0001628280-24-046673.md) | not reported | [0.60](/filings/0001628280-25-024142.md) | [0.49](/filings/0001628280-25-037646.md) | [0.77](/filings/0001628280-25-050843.md) | not reported | [0.57](/filings/0001628280-26-032774.md) | [(0.56)](/filings/0001628280-26-051368.md) | [0.29](/filings/0001628280-25-050843.md) | not reported | [1.00](/filings/0001628280-26-032774.md) | [0.38](/filings/0001628280-26-051368.md) |
| Basic EPS | $ per share | [0.88](/filings/0001628280-24-046673.md) | not reported | [0.61](/filings/0001628280-25-024142.md) | [0.50](/filings/0001628280-25-037646.md) | [0.78](/filings/0001628280-25-050843.md) | not reported | [0.57](/filings/0001628280-26-032774.md) | [(0.56)](/filings/0001628280-26-051368.md) | [0.29](/filings/0001628280-25-050843.md) | not reported | [1.01](/filings/0001628280-26-032774.md) | [0.39](/filings/0001628280-26-051368.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [205](/filings/0001628280-25-009503.md) | [132](/filings/0001628280-25-024142.md) | [180](/filings/0001628280-25-037646.md) | not reported | [190](/filings/0001628280-26-012995.md) | [145](/filings/0001628280-25-024142.md) | [112](/filings/0001628280-25-037646.md) | not reported | [112](/filings/0001628280-26-012995.md) | not reported | not reported |
| Current assets | $m | [854](/filings/0001628280-24-046673.md) | [855](/filings/0001628280-25-009503.md) | [807](/filings/0001628280-25-024142.md) | [860](/filings/0001628280-25-037646.md) | [945](/filings/0001628280-25-050843.md) | [895](/filings/0001628280-26-012995.md) | [886](/filings/0001628280-26-032774.md) | [998](/filings/0001628280-26-051368.md) | [1,093](/filings/0001628280-25-050843.md) | [1,001](/filings/0001628280-26-051368.md) | [1,049](/filings/0001628280-26-032774.md) | [930](/filings/0001628280-26-051368.md) |
| Total assets | $m | [1,292](/filings/0001628280-24-046673.md) | [1,348](/filings/0001628280-25-009503.md) | [1,304](/filings/0001628280-25-024142.md) | [1,375](/filings/0001628280-25-037646.md) | [1,457](/filings/0001628280-25-050843.md) | [1,412](/filings/0001628280-26-012995.md) | [1,427](/filings/0001628280-26-032774.md) | [1,895](/filings/0001628280-26-051368.md) | [2,000](/filings/0001628280-25-050843.md) | [1,914](/filings/0001628280-26-051368.md) | [1,955](/filings/0001628280-26-032774.md) | [1,836](/filings/0001628280-26-051368.md) |
| Current liabilities | $m | [332](/filings/0001628280-24-046673.md) | [378](/filings/0001628280-25-009503.md) | [333](/filings/0001628280-25-024142.md) | [406](/filings/0001628280-25-037646.md) | [453](/filings/0001628280-25-050843.md) | [414](/filings/0001628280-26-012995.md) | [395](/filings/0001628280-26-032774.md) | [497](/filings/0001628280-26-051368.md) | [572](/filings/0001628280-25-050843.md) | [526](/filings/0001628280-26-051368.md) | [471](/filings/0001628280-26-032774.md) | [488](/filings/0001628280-26-051368.md) |
| Total liabilities | $m | [439](/filings/0001628280-24-046673.md) | [500](/filings/0001628280-25-009503.md) | [461](/filings/0001628280-25-024142.md) | [543](/filings/0001628280-25-037646.md) | [597](/filings/0001628280-25-050843.md) | [536](/filings/0001628280-26-012995.md) | [524](/filings/0001628280-26-032774.md) | [1,032](/filings/0001628280-26-051368.md) | [1,113](/filings/0001628280-25-050843.md) | [1,010](/filings/0001628280-26-051368.md) | [1,008](/filings/0001628280-26-032774.md) | [864](/filings/0001628280-26-051368.md) |
| Long-term debt | $m | not reported | not reported | not reported | [0.0](/filings/0001628280-25-037646.md) | [0.0](/filings/0001628280-25-050843.md) | [0.0](/filings/0001628280-26-012995.md) | [0.0](/filings/0001628280-26-032774.md) | [288](/filings/0001628280-26-051368.md) | [294](/filings/0001628280-25-050843.md) | [234](/filings/0001628280-26-051368.md) | [286](/filings/0001628280-26-032774.md) | [125](/filings/0001628280-26-051368.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [0.0](/filings/0001628280-25-037646.md) | not reported | [0.0](/filings/0001628280-25-037646.md) | not reported | [5.6](/filings/0001628280-26-051368.md) | not reported | [0.0](/filings/0001628280-26-051368.md) | not reported | [0.0](/filings/0001628280-26-051368.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [837](/filings/0001628280-24-046673.md) | [830](/filings/0001628280-25-009503.md) | [825](/filings/0001628280-25-024142.md) | [808](/filings/0001628280-25-037646.md) | [834](/filings/0001628280-25-050843.md) | [848](/filings/0001628280-26-012995.md) | [875](/filings/0001628280-26-032774.md) | [833](/filings/0001628280-26-051368.md) | [851](/filings/0001628280-25-050843.md) | [866](/filings/0001628280-26-051368.md) | [913](/filings/0001628280-26-032774.md) | [940](/filings/0001628280-26-051368.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.5) d](/filings/0001628280-24-046673.md) | [151 d](/filings/0001628280-26-012995.md) | [(15.7)](/filings/0001628280-25-024142.md) | [110 d](/filings/0001628280-25-037646.md) | [0.4 d](/filings/0001628280-25-050843.md) | [104 d](/filings/0001628280-26-012995.md) | [(18.8)](/filings/0001628280-26-032774.md) | [66.5 d](/filings/0001628280-26-051368.md) | [23.4 d](/filings/0001628280-25-050843.md) | [91.1 d](/filings/0001628280-26-012995.md) | [(55.3)](/filings/0001628280-26-032774.md) | [205 d](/filings/0001628280-26-051368.md) |
| Capital expenditure | $m | [6.1](/filings/0001628280-23-038128.md) | [5.6 d](/filings/0001628280-26-012995.md) | [4.0](/filings/0001628280-25-024142.md) | [5.3](/filings/0001628280-24-034229.md) | [7.4 d](/filings/0001628280-25-050843.md) | [9.3 d](/filings/0001628280-26-012995.md) | [9.8](/filings/0001628280-26-032774.md) | [7.7 d](/filings/0001628280-26-051368.md) | [14.8 d](/filings/0001628280-25-050843.md) | [10.3 d](/filings/0001628280-26-012995.md) | [5.9](/filings/0001628280-26-032774.md) | [8.5 d](/filings/0001628280-26-051368.md) |
| Dividends paid | $m | [15.7 d](/filings/0001628280-24-046673.md) | [15.6 d](/filings/0001628280-26-012995.md) | [15.4](/filings/0001628280-25-024142.md) | [15.3 d](/filings/0001628280-25-037646.md) | [15.2 d](/filings/0001628280-25-050843.md) | [15.2 d](/filings/0001628280-26-012995.md) | [15.2](/filings/0001628280-26-032774.md) | [15.2 d](/filings/0001628280-26-051368.md) | [15.3 d](/filings/0001628280-25-050843.md) | [15.3 d](/filings/0001628280-26-012995.md) | [15.3](/filings/0001628280-26-032774.md) | [15.4 d](/filings/0001628280-26-051368.md) |
| Share repurchases | $m | [40.0 d](/filings/0001628280-24-046673.md) | [38.1 d](/filings/0001628280-26-012995.md) | [37.3](/filings/0001628280-25-024142.md) | [38.2 d](/filings/0001628280-25-037646.md) | [20.2 d](/filings/0001628280-25-050843.md) | [2.6 d](/filings/0001628280-26-012995.md) | [7.8](/filings/0001628280-26-032774.md) | [0.4 d](/filings/0001628280-26-051368.md) | [0.2 d](/filings/0001628280-25-050843.md) | [5.2 d](/filings/0001628280-26-012995.md) | [7.4](/filings/0001628280-26-032774.md) | [1.0 d](/filings/0001628280-26-051368.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [77.4](/filings/0001628280-23-038128.md) | [75.9](/filings/0001628280-24-019938.md) | [74.9](/filings/0001628280-24-034229.md) | [74.1](/filings/0001628280-24-046673.md) | [72.9](/filings/0001628280-25-024142.md) | [72.0](/filings/0001628280-25-037646.md) | [71.6](/filings/0001628280-25-050843.md) | [71.1](/filings/0001628280-26-032774.md) | [70.9](/filings/0001628280-26-051368.md) | [71.2](/filings/0001628280-25-050843.md) | [71.9](/filings/0001628280-26-032774.md) | [72.2](/filings/0001628280-26-051368.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 73,177,095 at 2026-07-28, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051368.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.